Filing Details
- Accession Number:
- 0001181431-10-026157
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-12 13:00:00
- Reporting Period:
- 2010-05-10
- Filing Date:
- 2010-05-12
- Accepted Time:
- 2010-05-12 17:43:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
906709 | Nektar Therapeutics | NKTR | Pharmaceutical Preparations (2834) | 943134940 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1227886 | Robert Chess | C/O Nektar Therapeutics 201 Industrial Road San Carlos CA 94070 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-10 | 35,000 | $6.12 | 290,123 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-05-10 | 35,000 | $13.95 | 255,123 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Disposition | 2010-05-10 | 35,000 | $0.00 | 35,000 | $6.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,004 | 2012-10-30 | No | 4 | M | Direct |
Footnotes
- Transaction executed pursuant to a 10b5-1 plan adopted by the reporting person.
- This transaction was executed in multiple trades during the day at prices ranging from $13.57 to $14.11. The price reported above reflects the weighted-average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Shares subject to the stock option vested on a pro-rata monthly basis over five (5) years from the date of grant (Ocrtober 31, 2002).